In this article, we analyze the role of innovation and technology policy in concepts of modern industrial policy and … present current insights about its successful integration. The systemic innovation policy contributes substantially to the … principles for public policy and the higher diversification of policy tools. Past examples of biotechnology in the US and the …

We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

In the literature, it is widely discussed whether the pharmaceutical industry is going through an innovation crisis … progress in biotechnology and related disciplines has increased the opportunities to treat diseases, but the firms have …

Asia, have engaged in improving their innovation capability in the economic transition. First, I measured and compared … innovation capability of both countries by using not only various input and output indicators of innovation systems but also the … how both countries developed their innovation capabilities by focusing on their transformation of the national innovation …

essential role in transforming their national innovation systems so that they can be more adaptable to economic development. The … innovation activities. Balancing import of technology and indigenous R&D effort is another major theme. Innovation capability … influence on choice of innovation at the firm level, i.e., the decision at firm level in terms of indigenous R&D or import of …

This paper examines the effect of foreign direct investment (FDI) on domestic innovation based on a data set covering … show that there is a negative horizontal spillover effect of FDI on domestic innovation when the intellectual property …

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months)- about 44% of the total increase in longevity -and … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003-2013, by ….) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate … of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger …